Credit Suisse Ag Bionano Genomics, Inc. Transaction History

Credit Suisse Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$1.06 - $1.97 $81 - $151	77 Added 0.03%	234,528 $260,000
Q4 2022 Feb 13, 2023	BUY	$1.4 - $25.4 $5,630 - $102,158	4,022 Added 1.75%	234,451 $342,000
Q3 2022 Nov 10, 2022	BUY	$0.36 - $36.0 $12,889 - $1.29 Million	35,805 Added 18.4%	230,429 $421,000
Q2 2022 Aug 12, 2022	SELL	$12.3 - $27.3 $2,029 - $4,504	-165 Reduced 0.08%	194,624 $268,000
Q1 2022 May 16, 2022	BUY	$16.6 - $32.3 $266,679 - $518,899	16,065 Added 8.99%	194,789 $502,000
Q4 2021 Feb 14, 2022	SELL	$29.9 - $61.2 $84,736 - $173,440	-2,834 Reduced 1.56%	178,724 $535,000
Q3 2021 Nov 12, 2021	BUY	$51.4 - $68.2 $813,559 - $1.08 Million	15,828 Added 9.55%	181,558 $999,000
Q2 2021 Aug 16, 2021	BUY	$44.1 - $84.0 $7.31 Million - $13.9 Million	165,730 New	165,730 $1.22 Million

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $58M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.